Monday, September 23, 2019
- 1:45pm-3:15pm
-
Analysis of the Shape of the Gocovri Steady-state PK Profile: Implications for an Extended Release Product
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Ancillary Service Utilization and Impact in Huntington’s Disease
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Another mitochondrial disease mimic: Two Case reports of adult riboflavin transporter deficiency (RTD) type 2 with muscle adenosine monophosphate (AMP) deaminase deficiency
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Anthropometric Profile and Vitamin D Status in the Functional Performance of a Brazilian Elderly Parkinsonian Population
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Apathy : Clinical Correlates in Parkinson’s disease Psychosis
Psychiatric Manifestations · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Apomorphine induced hemolytic anemia: A case report and literature review
Neuropharmacology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Assessing the response to Levodopa/carbidopa intestinal gel infusion based on genetic status
Genetics · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Assessment of Caregiver Burden in Huntington’s disease
Huntington’s Disease · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 75
- Next Page»